INVO Bioscience Inc
NASDAQ:INVO
INVO Bioscience Inc
Interest Income Expense
INVO Bioscience Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
INVO Bioscience Inc
NASDAQ:INVO
|
Interest Income Expense
-$986.6k
|
CAGR 3-Years
30%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Interest Income Expense
-$384m
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-16%
|
|
Boston Scientific Corp
NYSE:BSX
|
Interest Income Expense
-$554m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-6%
|
|
Stryker Corp
NYSE:SYK
|
Interest Income Expense
$97m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Interest Income Expense
-$296m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Interest Income Expense
$227m
|
CAGR 3-Years
11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
29%
|
See Also
What is INVO Bioscience Inc's Interest Income Expense?
Interest Income Expense
-986.6k
USD
Based on the financial report for Dec 31, 2023, INVO Bioscience Inc's Interest Income Expense amounts to -986.6k USD.
What is INVO Bioscience Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-18%
Over the last year, the Interest Income Expense growth was -279%. The average annual Interest Income Expense growth rates for INVO Bioscience Inc have been 30% over the past three years , -18% over the past five years .